VYOME HOLDINGS, INC. Operating Cash Flow
VYOME HOLDINGS, INC. (HIND) reported Operating Cash Flow of -$2.34 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-12
- VYOME HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$903.71K.
- VYOME HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.44M.
- VYOME HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.48M.
- VYOME HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.76M.
- VYOME HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$3.75M.
- VYOME HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$614.14K.
- VYOME HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$16.96M.
- VYOME HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$21.90M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$903.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$2.34M 10-Q · filed 2026-08-12 | -$3.82M derived: sum of 3 quarters · filed 2026-08-12 | -$5.58M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | -$1.44M 10-Q · filed 2026-05-12 | -$2.91M derived: sum of 2 quarters · filed 2026-05-12 | -$4.68M derived: sum of 3 quarters · filed 2026-05-12 | -$4.98M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | -$1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$3.24M derived: sum of 2 quarters · filed 2026-03-18 | -$3.55M derived: sum of 3 quarters · filed 2026-08-12 | -$3.75M 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | -$1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$2.07M derived: sum of 2 quarters · filed 2026-08-12 | -$2.27M 10-Q · filed 2025-11-14 | -$2.27M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | -$306.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$509.78K 10-Q · filed 2026-08-12 | -$6.61M 10-Q · filed 2025-08-14 | -$512.75K derived: sum of 3 quarters · filed 2026-08-12 | -$886.87K derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-03-31 | -$203.53K 10-Q · filed 2026-05-12 | -$2.12M 10-Q · filed 2025-05-20 | -$206.50K derived: sum of 2 quarters · filed 2026-05-12 | -$580.62K derived: sum of 3 quarters · filed 2026-05-12 | $1.25M derived: sum of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | -$2.97K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$377.08K derived: sum of 2 quarters · filed 2026-03-18 | $1.46M derived: sum of 3 quarters · filed 2026-03-18 | -$614.14K 10-K · filed 2026-03-18 | -$4.43M 10-K · filed 2025-04-04 | |||
| 2024-09-30 | -$374.12K derived: 10-Q 9 month − 8-K 6 month · filed 2025-11-14 | $1.46M derived: sum of 2 quarters · filed 2025-11-14 | -$611.17K 10-Q · filed 2025-11-14 | -$3.74M 10-Q · filed 2024-11-14 | -$3.07M derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | $1.83M derived: 8-K 6 month − 10-Q 3 month · filed 2025-09-02 | -$237.05K 8-K · filed 2025-09-02 | -$3.43M 10-Q · filed 2024-08-14 | -$2.69M derived: sum of 3 quarters · filed 2025-09-02 | -$5.47M derived: sum of 4 quarters · filed 2025-09-02 | |||
| 2024-03-31 | -$2.07M 10-Q · filed 2025-05-20 | -$4.53M derived: sum of 2 quarters · filed 2025-05-20 | -$7.31M derived: sum of 3 quarters · filed 2025-05-20 | -$13.97M derived: sum of 4 quarters · filed 2025-05-20 | ||||
| 2023-12-31 | -$2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | -$5.24M derived: sum of 2 quarters · filed 2025-04-04 | -$11.90M derived: sum of 3 quarters · filed 2025-04-04 | -$16.96M 10-K · filed 2025-04-04 | ||||
| 2023-09-30 | -$2.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$9.44M derived: sum of 2 quarters · filed 2024-11-14 | -$14.50M 10-Q · filed 2024-11-14 | -$17.33M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$6.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$11.72M 10-Q · filed 2024-08-14 | -$14.55M derived: sum of 3 quarters · filed 2024-08-14 | -$19.82M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$5.06M 10-Q · filed 2024-05-15 | -$7.89M derived: sum of 2 quarters · filed 2024-05-15 | -$13.16M derived: sum of 3 quarters · filed 2024-05-15 | -$19.59M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$8.10M derived: sum of 2 quarters · filed 2024-04-01 | -$14.52M derived: sum of 3 quarters · filed 2024-04-01 | -$21.90M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | -$5.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$11.70M derived: sum of 2 quarters · filed 2023-11-09 | -$19.07M 10-Q · filed 2023-11-09 | -$19.07M 10-Q · filed 2022-11-14 | -$22.50M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | -$6.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$13.80M 10-Q · filed 2023-08-07 | -$17.23M derived: sum of 3 quarters · filed 2023-08-07 | -$25.03M derived: sum of 4 quarters · filed 2023-08-07 | ||||
| 2022-03-31 | -$7.38M 10-Q · filed 2023-05-15 | -$10.80M derived: sum of 2 quarters · filed 2023-05-15 | -$18.60M derived: sum of 3 quarters · filed 2023-05-15 | -$20.79M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$3.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$11.23M derived: sum of 2 quarters · filed 2023-04-17 | -$13.41M derived: sum of 3 quarters · filed 2023-04-17 | -$15.38M 10-K · filed 2023-04-17 | ||||
| 2021-09-30 | -$7.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$9.99M derived: sum of 2 quarters · filed 2022-11-14 | -$11.95M 10-Q · filed 2022-11-14 | -$13.71M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19 | -$4.15M 10-Q · filed 2022-08-19 | -$5.91M derived: sum of 3 quarters · filed 2022-08-19 | -$6.89M derived: sum of 4 quarters · filed 2022-08-19 | ||||
| 2021-03-31 | -$1.96M 10-Q · filed 2022-05-23 | -$4.44M 10-Q · filed 2021-05-12 | -$3.72M derived: sum of 2 quarters · filed 2022-05-23 | -$4.70M derived: sum of 3 quarters · filed 2022-05-23 | -$5.70M derived: sum of 4 quarters · filed 2022-05-23 | |||
| 2020-12-31 | -$1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | -$2.74M derived: sum of 2 quarters · filed 2022-04-08 | -$3.74M derived: sum of 3 quarters · filed 2022-04-08 | -$8.55M 10-K · filed 2022-04-08 | -$10.41M 10-K · filed 2021-03-12 | |||
| 2020-09-30 | -$976.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$1.97M derived: sum of 2 quarters · filed 2021-11-12 | -$6.79M 10-Q · filed 2021-11-12 | -$8.85M 10-Q · filed 2020-11-06 | -$11.67M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | -$998.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$5.81M 10-Q · filed 2021-08-16 | -$7.56M 10-Q · filed 2020-07-30 | -$10.69M derived: sum of 3 quarters · filed 2021-08-16 | -$14.68M derived: sum of 4 quarters · filed 2021-08-16 | |||
| 2020-03-31 | -$4.81M 10-Q · filed 2021-05-12 | -$9.69M derived: sum of 2 quarters · filed 2021-05-12 | -$13.68M derived: sum of 3 quarters · filed 2021-05-12 | -$18.04M derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | -$4.88M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$8.87M derived: sum of 2 quarters · filed 2021-03-12 | -$13.22M derived: sum of 3 quarters · filed 2021-03-12 | -$22.87M 10-K · filed 2021-03-12 | ||||
| 2019-09-30 | -$3.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$8.35M derived: sum of 2 quarters · filed 2020-11-06 | -$17.99M 10-Q · filed 2020-11-06 | -$23.40M derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | -$4.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$14.00M 10-Q · filed 2020-07-30 | -$19.41M derived: sum of 3 quarters · filed 2020-07-30 | -$24.71M derived: sum of 4 quarters · filed 2020-07-30 | ||||
| 2019-03-31 | -$9.64M 10-Q · filed 2020-06-19 | -$15.06M derived: sum of 2 quarters · filed 2020-06-19 | -$20.35M derived: sum of 3 quarters · filed 2020-06-19 | -$28.47M derived: sum of 4 quarters · filed 2020-06-19 | ||||
| 2018-12-31 | -$5.42M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$10.71M derived: sum of 2 quarters · filed 2020-02-27 | -$18.83M derived: sum of 3 quarters · filed 2020-02-27 | -$29.43M 10-K · filed 2020-02-27 | ||||
| 2018-09-30 | -$5.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$13.41M derived: sum of 2 quarters · filed 2019-11-08 | -$24.02M 10-Q · filed 2019-11-08 | -$33.21M derived: sum of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | -$8.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | -$18.72M 10-Q · filed 2019-07-24 | -$27.92M derived: sum of 3 quarters · filed 2019-07-24 | -$34.94M derived: sum of 4 quarters · filed 2019-07-24 | ||||
| 2018-03-31 | -$10.60M 10-Q · filed 2019-05-10 | -$19.80M derived: sum of 2 quarters · filed 2019-05-10 | -$26.82M derived: sum of 3 quarters · filed 2019-05-10 | -$32.87M derived: sum of 4 quarters · filed 2019-05-10 | ||||
| 2017-12-31 | -$9.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | -$16.22M derived: sum of 2 quarters · filed 2019-02-22 | -$22.27M derived: sum of 3 quarters · filed 2019-02-22 | -$30.62M 10-K · filed 2019-02-22 | ||||
| 2017-09-30 | -$7.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | -$13.07M derived: sum of 2 quarters · filed 2018-11-02 | -$21.43M 10-Q · filed 2018-11-02 | -$27.20M derived: sum of 4 quarters · filed 2018-11-02 | ||||
| 2017-06-30 | -$6.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$14.41M 10-Q · filed 2018-08-02 | -$20.18M derived: sum of 3 quarters · filed 2018-08-02 | -$25.11M derived: sum of 4 quarters · filed 2018-08-02 | ||||
| 2017-03-31 | -$8.35M 10-Q · filed 2018-05-10 | -$14.13M derived: sum of 2 quarters · filed 2018-05-10 | -$19.06M derived: sum of 3 quarters · filed 2018-05-10 | -$22.74M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | -$5.78M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | -$10.71M derived: sum of 2 quarters · filed 2018-03-05 | -$14.39M derived: sum of 3 quarters · filed 2018-03-05 | -$19.37M 10-K · filed 2018-03-05 | ||||
| 2016-09-30 | -$4.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | -$8.61M derived: sum of 2 quarters · filed 2017-11-03 | -$13.59M 10-Q · filed 2017-11-03 | |||||
| 2016-06-30 | -$3.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$8.66M 10-Q · filed 2017-08-02 | ||||||
| 2016-03-31 | -$4.98M 10-Q · filed 2017-05-10 | |||||||
| 2015-12-31 | -$11.39M 10-K · filed 2018-03-05 | |||||||
| 2014-12-31 | -$9.91M 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |